Gabapentin Capsule
Product Images NDC 64380-869

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 64380-869). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cockcroft And Gault Equation (F0697d39 1473 4df8 B955 8ad587c02c5f 01)

A formula for calculating creatinine clearance (CLCr) based on age, weight, serum creatinine, and a correction factor for female patients, shown in a mathematical expression format.*

FDA Label Image

Image (F0697d39 1473 4df8 B955 8ad587c02c5f 02)

Chemical structure of gabapentin, showing a cyclohexane ring attached to an amino group (CH2NH2) and a carboxylic acid group (CH2CO2H).*

FDA Label Image

Figure 1. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 1 (F0697d39 1473 4df8 B955 8ad587c02c5f 03)

Line graph comparing mean pain scores over 8 weeks between placebo and gabapentin 3600 mg/day groups. The x-axis shows weeks from baseline to week 8, and the y-axis shows mean pain score ranging from 0 to 10. Annotations indicate a 4-week dose titration period followed by a 4-week fixed dose period. Gabapentin group shows a decreasing pain score trend, while placebo remains relatively stable.*

FDA Label Image

Figure 2. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 2 (F0697d39 1473 4df8 B955 8ad587c02c5f 04)

A line graph showing mean pain scores over a 7-week period with a 3-week dose titration followed by a 4-week fixed dose period. It compares placebo with gabapentin at daily doses of 1800 mg and 2400 mg, tracking pain scores from baseline through week 7.*

FDA Label Image

Figure 3. Proportion Of Responders (patients With ≥ 50% Reduction In Pain Score) At Endpoint: Controlled Phn Studies (F0697d39 1473 4df8 B955 8ad587c02c5f 05)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and gabapentin (GBP) doses in two studies. Study 1 shows placebo at 12% and GBP 3600 mg at 29%. Study 2 shows placebo at 14%, GBP 1800 mg at 32%, and GBP 2400 mg at 34%. Statistical significance markers indicate p-values less than 0.01 and 0.001 for comparisons.*

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥ 12 Years Of Age With Partial Seizures (F0697d39 1473 4df8 B955 8ad587c02c5f 06)

A scatter plot chart showing the percentage difference on the y-axis and daily dose in milligrams (mg) on the x-axis with data points from three studies labeled as study a, study b, and study c. The chart presents variation in difference across doses ranging from 600 mg to 1800 mg.*

FDA Label Image

Gabapentin Capsules 100mg (100S)

Gabapentin Capsules, USP 100 mg oral capsules label by Strides Pharma Science Limited. The label includes dosing and storage instructions, container handling warnings, and manufacturer details for 500 capsules. It shows the NDC 64380-867-07 and advises dispensing the Medication Guide to patients.*

FDA Label Image

Gabapentin Capsules 300mg (100S)

Label for Gabapentin Capsules USP, 300 mg oral capsules, manufactured by Strides Pharma Science Limited. The label states storage instructions, dosage form, and that the bottle contains 500 capsules. It includes warnings to keep out of reach of children and to keep the container tightly closed. The label also references accompanying prescribing information and a Medication Guide for each patient.*

FDA Label Image

Gabapentin Capsules 400mg (100S)

Label for Gabapentin Capsules, USP 400 mg by Strides Pharma Science Limited. The label indicates oral capsules available in a 500-count bottle. It includes storage instructions at 25°C (77°F), dosage guidance referencing accompanying literature, and warnings to keep the container tightly closed and out of reach of children. Manufactured by Strides Pharma Science Ltd, distributed by Strides Pharma Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.